Bio Essence Corporation
BIOE
$0.206
-$0.008-3.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -43.93% | -57.85% | 22.34% | 12.75% | -20.02% |
| Total Depreciation and Amortization | -74.47% | -349.15% | -222.22% | -55.74% | -67.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 497.02% | 366.47% | -68.52% | -108.74% | -31.59% |
| Change in Net Operating Assets | 414.80% | 242.63% | 28.19% | -130.16% | -28.44% |
| Cash from Operations | 160.83% | 99.65% | 4.21% | -41.90% | -45.85% |
| Capital Expenditure | -- | -100.00% | -63.64% | 2.70% | 2.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.89% | -865.93% | -58.85% | -54.82% | -54.82% |
| Total Debt Issued | -100.00% | -68.29% | -5.63% | 45.15% | 40.94% |
| Total Debt Repaid | -47,061.54% | -346.74% | 188.09% | -729.41% | 35.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 86.34% | -1,014.74% | -1,014.74% | -1,014.74% | -- |
| Cash from Financing | -156.03% | -87.39% | 1.45% | 42.93% | 44.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.67% | 6,080.00% | 1,720.00% | -- | -201.67% |